RSS
Optimapharm
European CRO expands office network to New York and Budapest
European contract research organisation (CRO), Optimapharm, has expanded its office network to New York, USA, and Budapest, Hungary. Read more
Regional CRO strengthens position in pharma and biotech through acquisition
Regional clinical research organisation (CRO), Optimapharm, has acquired the Czech company MKS Research to strengthen its portfolio of clients in the pharma and biotech industries. Read more
